|
Main characteristics (N = 15)
|
N° (%)
|
|---|
|
Age, years
|
|
Median (range)
|
52 (42–68)
|
|
Sex
|
|
Male
|
9 (60)
|
|
Female
|
6 (40)
|
|
ECOG performance status
|
|
0
|
12 (80)
|
|
1
|
3 (20)
|
|
Histological grade
|
|
High
|
5 (33)
|
|
Low
|
10 (67)
|
|
Time from CRS + HIPEC to relapse
|
|
Median (range, months)
|
13 (5–36)
|
|
≤12 months
|
7 (47)
|
|
>12 months
|
8 (53)
|
|
PCI at the time of CRS + HIPEC
|
|
Median (range)
|
27 (8–39)
|
|
Completeness of cytoreduction
|
|
CC-0
|
8 (53)
|
|
CC-1
|
7 (47)
|
-
CRS cytoreductive surgery; HIPEC hyperthermic intraperitoneal chemotherapy; PCI peritoneal carcinomatosis index; CC completeness of cytoreduction score
